Literature DB >> 14574642

[Cost-effectiveness of prophylaxis and treatment of influenza].

R Rychlik1, T Heinen-Kammerer, H Rusche, J Piercy, P Scuffham, Y Zöllner.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 14574642     DOI： 10.1055/s-2003-43100

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN： 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  5 in total

1.  Strategies for Improving Influenza Vaccination Rates in Patients with Chronic Renal Disease.

Authors:  Kevin Schulte; Helen Schierke; Miguel Tamayo; Lutz Hager; Roland Engehausen; Matthias Raspe; Ralf-Harto Hübner; Georg Schlieper; Christoph Borzikowsky; Andreas Urbschat; Sven Auerswald; Ulrich Kunzendorf; Thorsten Feldkamp
Journal:  Dtsch Arztebl Int       Date:  2019-06-10       Impact factor: 5.594

2.  Cost-effectiveness of polysaccharide pneumococcal vaccination in people aged 65 and above in Poland.

Authors:  Pawel Grzesiowski; Raquel Aguiar-Ibáñez; Aleksandra Kobryń; Laure Durand; Pierre-Emmanuel Puig
Journal:  Hum Vaccin Immunother       Date:  2012-10-01       Impact factor: 3.452

3.  Cost for physician-diagnosed influenza and influenza-like illnesses on primary care level in Germany--results of a database analysis from May 2010 to April 2012.

Authors:  Birgit Ehlken; Anastassia Anastassopoulou; Johannes Hain; Claudia Schröder; Klaus Wahle
Journal:  BMC Public Health       Date:  2015-06-21       Impact factor: 3.295

4.  Cost-benefit analysis of influenza vaccination in a public healthcare unit.

Authors:  Giorgio L Colombo; Antonio Ferro; Marta Vinci; Maria Zordan; Giulio Serra
Journal:  Ther Clin Risk Manag       Date:  2006-06       Impact factor: 2.423

5.  The provision of pharmaceutical advice improves patient vaccination status.

Authors:  Joerg Fuchs
Journal:  Pharm Pract (Granada)       Date:  2006-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.